Skip to main content

Back to all tickers

ProShares Ultra PLTR (PLTA) stock forecast & analysis

1 analysis in the last 30 days. Latest: .

Market Scanner’s AI analysis of ProShares Ultra PLTR (PLTA), updated August 2026: PLTA's technical indicators showed mixed signals with short-term weakness and overbought conditions, while fundamental and news data were unavailable.

Summary

PLTA's technical indicators showed mixed signals with short-term weakness and overbought conditions, while fundamental and news data were unavailable.

Recent analyses for PLTA examined technical indicators, noting a medium-term downtrend indicated by SMAs and short-term weakness suggested by the 10-day EMA below the 50-day SMA. The RSI and MFI were in overbought territory, signaling strong buying pressure, though the MACD suggested waning momentum. Fundamental data and recent news were not available for review.

PLTA news & sentiment

Social media discussion and news sentiment for PLTA were not covered in the provided notes.

PLTA technical picture

PLTA's technical indicators showed a medium-term downtrend with the 50-day SMA below the 200-day SMA, and short-term weakness as the 10-day EMA fell below the 50-day SMA. Momentum readings were mixed, with RSI and MFI in overbought territory, while the MACD suggested waning momentum.

Factors discussed — upside

  • RSI above overbought threshold (70.93)
  • MFI in overbought territory (78.58)
  • Positive MACD (0.091)

Factors discussed — risks

  • 50-day SMA below 200-day SMA (12.36 vs 20.22)
  • 10-day EMA below 50-day SMA (12.03)
  • MACD very close to zero, suggesting waning momentum
  • Fundamental data unavailable
  • No relevant news found
  • Technical Indicators
  • Moving Averages
  • Momentum Indicators
  • Data Availability

Summary updated .

Analyses

Recent PLTA.US analyses are locked — sign in to read them or generate a fresh one.

CaseDescriptionDate

Frequently asked questions

What is the bull case for ProShares Ultra PLTR?
The analyses noted that the Relative Strength Index (RSI) and Money Flow Index (MFI) were in overbought territory, indicating strong buying pressure. Additionally, the Moving Average Convergence Divergence (MACD) was positive, suggesting upward momentum.
What are the risks for ProShares Ultra PLTR?
The company's technical indicators showed a medium-term downtrend with the 50-day Simple Moving Average below the 200-day Simple Moving Average, and short-term weakness as the 10-day Exponential Moving Average was below the 50-day SMA. The MACD was also very close to zero, suggesting momentum may be waning. Furthermore, fundamental data and recent news were unavailable for review.
Is ProShares Ultra PLTR bullish or bearish?
Recent AI analyses of ProShares Ultra PLTR examined factors on both sides. Discussed upside: The analyses noted that the Relative Strength Index (RSI) and Money Flow Index (MFI) were in overbought territory, indicating strong buying pressure. Additionally, the Moving Average Convergence Divergence (MACD) was positive, suggesting upward momentum. Discussed risks: The company's technical indicators showed a medium-term downtrend with the 50-day Simple Moving Average below the 200-day Simple Moving Average, and short-term weakness as the 10-day Exponential Moving Average was below the 50-day SMA. The MACD was also very close to zero, suggesting momentum may be waning. Furthermore, fundamental data and recent news were unavailable for review. These are descriptive observations, not a recommendation.
What is the latest sentiment on ProShares Ultra PLTR?
Social media discussion and news sentiment for PLTA were not covered in the provided notes.

Bundles used
gemini-low-v2

Sign in to read every PLTA.US report in the library

Each analysis includes the full reasoning, dissent, and decision rationale from the structured AI pipeline.



Most analyzed tickers

Market Scanner content is AI-generated for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. Public pages show historical sample analyses, not current guidance.